FDA MedWatch Alert:
Public Health Advisory: Antidepressant Use in Children, Adolescents, and Adults

The FDA asked manufacturers of the following antidepressant drugs to include in their labeling a Warning statement that recommends close observation of adult and pediatric patients for worsening depression or the emergence of suicidality when treated with these agents. The drugs that are the focus of this new Warning are:

and Remeron (mirtazapine).

See the 2004 MedWatch safety summary, including links to the drug information page and the FDA Public Health Advisory, at:

http://www.fda.gov/medwatch/SAFETY/2004/safety04.htm#antidepressants

The above is for general informational purposes only. Always consult your physician regarding specific medical issues and call Hatzalah or your local ambulance service in the event of an emergency.

Back to Digest Index